Related Experiment Video

Updated: Aug 29, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Cirrhotic hepatocytes exhibit decreased TGFbeta growth inhibition associated with downregulated Smad protein

Patricia A Lange1, Charles M Samson, Mark A Bird

  • 1Division of Gastrointestinal Surgery, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7081, USA.

Biochemical and Biophysical Research Communications
|December 31, 2003
PubMed

Insights

Resistance to transforming growth factor-beta (TGFbeta) aids malignant transformation. This study found cirrhotic hepatocytes exhibit impaired TGFbeta-mediated growth inhibition due to reduced Smad protein expression and DNA binding activity.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-beta (TGFbeta) regulates hepatocyte growth via cell cycle arrest and apoptosis.
  • Resistance to TGFbeta signaling is a key mechanism in malignant transformation.

Purpose of the Study:

  • To investigate the differential effects of TGFbeta on growth inhibition in normal versus cirrhotic hepatocytes.
  • To elucidate the molecular mechanisms underlying impaired TGFbeta response in cirrhosis.

Main Methods:

  • Induction of cirrhosis in a mouse model.
  • Isolation of normal and cirrhotic hepatocytes via collagenase perfusion.
  • Treatment with TGFbeta and assessment of DNA synthesis, Smad protein expression, and DNA binding activity.

Main Results:

  • TGFbeta significantly reduced DNA synthesis in normal hepatocytes (87%) compared to cirrhotic hepatocytes (68%).
  • Cirrhotic hepatocytes showed decreased Smad protein expression and suppressed Smad 2/3/4 complex formation.
  • A reduction in DNA binding activity was observed in cirrhotic hepatocytes post-TGFbeta treatment.

Conclusions:

  • Impaired TGFbeta-mediated growth inhibition in cirrhotic hepatocytes is linked to diminished Smad protein expression.
  • These molecular alterations may contribute to the progression of liver disease and malignant transformation in cirrhosis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...